New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline

Mycobacterium tuberculosis develops spontaneous resistance mutants to virtually every drug in use. Courses of therapy select for these mutants and drug-resistant organisms emerge. The development of drug-resistant organisms has reached the point that drug resistance now threatens to undermine global...

Descripción completa

Detalles Bibliográficos
Autores principales: Leibert, Eric, Danckers, Mauricio, Rom, William N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122575/
https://www.ncbi.nlm.nih.gov/pubmed/25114537
http://dx.doi.org/10.2147/TCRM.S37743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122575/
https://www.ncbi.nlm.nih.gov/pubmed/25114537
http://dx.doi.org/10.2147/TCRM.S37743

Ejemplares similares